Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.

Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG: Delisting agreement and announced delisting tender offer eieich, March 31, 2025: Biotest AG (ISIN ...

EQS-News: Biotest AG / Key word (s): Annual Report Biotest AG increases sales by 6% in financial year 2024 31.03.2025 / 07:00 CET/CEST The issuer is solely responsible for the content of this ...

The Spanish company’s Biotest subsidiary has reported top-line results of the phase 3 AdFirst trial of the concentrated preparation of fibrinogen, called BT524, which show it is at least as ...

LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest: Biotest AG Attn.